A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of Netakimab in Children with Moderate to Severe Plaque Psoriasis
Latest Information Update: 17 Oct 2024
At a glance
- Drugs Netakimab (Primary) ; Adalimumab
- Indications Psoriasis
- Focus Registrational; Therapeutic Use
- Acronyms PLANETA-KIDS
- Sponsors Biocad
Most Recent Events
- 24 Jun 2019 New trial record
- 07 May 2019 According to an Biocad Media release, the company plans to initiate a pivotal clinical trial of netakimab in psoriasis in Europe in the 4th quarter of 2019.